TEVA 6.000% 01Dec2032 Corp (USD)

Bond Factsheet

Teva Pharmaceutical Finance Netherlands III B.V.

Indicative

Full Lot

Bid Price

100.322

Change in Bid Price

0.532

Bid Yield (%)

5.933 %

Change in Bid Yield

remove 0.106

Ask Price

100.795

Change in Ask Price

0.506

Ask Yield (%)

5.837 %

Change in Ask Yield

remove 0.103

Indicative price as of 02 Oct 2026, 4:33pm

chevron_leftchevron_right

Bond Information

Teva Pharmaceutical Finance Netherlands III B.V. operates as a special purpose entity. The Company was formed for the purpose of issuing debt securities to repay existing credit facilities, refinance indebtedness, and for acquisition purposes.

Bond Issuer

Teva Pharmaceutical Finance Netherlands III B.V.

Guarantor

Parent & Subsidiaries

Announcement Date

20 May 2025

Issue Date

28 May 2025

Maturity Date

01 Dec 2032

Years to Maturity / Next Call

6.162 / 5.913

Modified Duration

4.989 @ 02 Oct 2026

Issue / Reoffer Price

99.256

Issue / Reoffer Yield

6.125

Coupon Type

Fixed

Annual Coupon Rate

6.000

Coupon Frequency

Semi Annually

Seniority

Senior Unsecured

Reference Rate

ISIN

US88167AAT88

CUSIP

88167AAT8

Bond Currency

USD

Total Issue Size

500,000,000

Min. Investment Quantity (Nominal)

USD 200,000

Incremental Quantity (Nominal)

USD 1,000

Bond Type

Corporate

Bond Sector

Health Care

Bond Sub Sector

Pharmaceuticals

Issuer Credit Rating (S&P/ Fitch)

***/ N.R

Bond Credit Rating (S&P/ Fitch)

***/ BBB-

Shariah Compliant

Exchange Listed

Others

Bond Feature(s)

Issuer Call

If we elect to redeem the 2032 USD notes at any time on or after September 1, 2032 (three months prior to the maturity date of the 2032 USD notes) or the 2030 USD notes at any time on or after September 1, 2030 (three months prior to the maturity date of the 2030 USD notes), we may redeem the USD notes, in whole or in part, in each case upon at least 10 days’, but not more than 60 days’, prior notice at a redemption price equal to 100% of the principal amount of the USD notes then outstanding to be redeemed plus accrued and unpaid interest thereon, if any, to, but not including, the redemption date. See “Description of the USD Notes and the Guarantees—Optional Redemption.”

Make Whole Call

Teva Finance III and Teva Finance IV, as applicable, may redeem the USD notes of any series for which they are the issuer, in whole or in part, at any time or from time to time, upon at least 10 days’, but not more than 60 days’, prior notice. This redemption notice and the redemption may, at Teva Finance III’s and Teva Finance IV’s discretion, be subject to one or more conditions precedent. The USD notes will be redeemable at a redemption price equal to the greater of

(1) 100% of the principal amount of the USD notes to be redeemed and

(2) the sum of the present values of the Remaining Scheduled Payments (as defined under “Description of the USD Notes and the Guarantees—Optional Redemption by the Issuer”) on the USD notes being redeemed discounted, on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months), at a rate equal to the sum of the Treasury Rate (as defined in “Description of the USD Notes and the Guarantees— Optional Redemption by the Issuer”) plus 50 basis points, in the case of the 2032 USD notes and 50 basis points, in the case of the 2030 USD notes, plus in each case accrued and unpaid interest thereon, if any, to, but not including, the redemption date.

Make whole call until September 1, 2032.

Bondsupermart strives to ensure the accuracy and relevance of the information provided here. If the information is not up-to-date or erroneous, we appreciate feedback to keep it accurate.

Coupon Dates	Coupon Receive	Principal Amount	Cash Flow

No Data